SIP
ALXN

Stoneridge Investment Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Stoneridge Investment Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-13,285
Closed -$2.02M – 255
2014
Q1 		$2.02M Buy
+13,285
New +$2.02M 0.39% 76